Mechanistic Target of Rapamycin Complex 1 Signaling Modulates Vascular Endothelial Function Through Reactive Oxygen Species

J Am Heart Assoc. 2019 May 7;8(9):e010662. doi: 10.1161/JAHA.118.010662.

Abstract

Background The mechanistic target of rapamycin complex 1 ( mTORC 1) is an important intracellular energy sensor that regulates gene expression and protein synthesis through its downstream signaling components, the S6-kinase and the ribosomal S6 protein. Recently, signaling arising from mTORC 1 has been implicated in regulation of the cardiovascular system with implications for disease. Here, we examined the contribution of mTORC 1 signaling to the regulation of vascular function. Methods and Results Activation of mTORC 1 pathway in aortic rings with leucine or an adenoviral vector expressing a constitutively active S6-kinase reduces endothelial-dependent vasorelaxation in an mTORC 1-dependent manner without affecting smooth muscle relaxation responses. Moreover, activation of mTORC 1 signaling in endothelial cells increases reactive oxygen species ( ROS ) generation and ROS gene expression resulting in a pro-oxidant gene environment. Blockade of ROS signaling with Tempol restores endothelial function in vascular rings with increased mTORC 1 activity indicating a crucial interaction between mTORC 1 and ROS signaling. We then tested the role of nuclear factor-κB transcriptional complex in connecting mTORC 1 and ROS signaling in endothelial cells. Blockade of inhibitor of nuclear factor κ-B kinase subunit β activity with BMS -345541 prevented the increased ROS generation associated with increased mTORC 1 activity in endothelial cells but did not improve vascular endothelial function in aortic rings with increased mTORC 1 and ROS signaling. Conclusions These results implicate mTORC 1 as a critical molecular signaling hub in the vascular endothelium in mediating vascular endothelial function through modulation of ROS signaling.

Keywords: NFκB; endothelial cell; endothelial function; mechanistic target of rapamycin complex 1; oxidative stress; vascular biology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Aorta / drug effects
  • Aorta / metabolism*
  • Aorta / physiopathology
  • Cyclic N-Oxides / pharmacology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology
  • I-kappa B Kinase / antagonists & inhibitors
  • Imidazoles / pharmacology
  • Mechanistic Target of Rapamycin Complex 1 / drug effects
  • Mechanistic Target of Rapamycin Complex 1 / metabolism*
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / metabolism*
  • Mesenteric Arteries / physiopathology
  • Mice
  • Myography
  • Organ Culture Techniques
  • Quinoxalines / pharmacology
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction
  • Spin Labels
  • Vasodilation / drug effects

Substances

  • 4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline
  • Antioxidants
  • Cyclic N-Oxides
  • Imidazoles
  • Quinoxalines
  • Reactive Oxygen Species
  • Spin Labels
  • Mechanistic Target of Rapamycin Complex 1
  • I-kappa B Kinase
  • Ikbkb protein, mouse
  • tempol